589 related articles for article (PubMed ID: 26085683)
1. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
[TBL] [Abstract][Full Text] [Related]
2. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
[TBL] [Abstract][Full Text] [Related]
3. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.
Tsai RK; Rodriguez PL; Discher DE
Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253
[TBL] [Abstract][Full Text] [Related]
4. 'Clustering' SIRPα into the plasma membrane lipid microdomains is required for activated monocytes and macrophages to mediate effective cell surface interactions with CD47.
Ha B; Lv Z; Bian Z; Zhang X; Mishra A; Liu Y
PLoS One; 2013; 8(10):e77615. PubMed ID: 24143245
[TBL] [Abstract][Full Text] [Related]
5. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
Barclay AN; Van den Berg TK
Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
[TBL] [Abstract][Full Text] [Related]
6. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.
Bian Z; Shi L; Guo YL; Lv Z; Tang C; Niu S; Tremblay A; Venkataramani M; Culpepper C; Li L; Zhou Z; Mansour A; Zhang Y; Gewirtz A; Kidder K; Zen K; Liu Y
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5434-43. PubMed ID: 27578867
[TBL] [Abstract][Full Text] [Related]
7. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS
Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180
[TBL] [Abstract][Full Text] [Related]
8. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
[TBL] [Abstract][Full Text] [Related]
9. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
[TBL] [Abstract][Full Text] [Related]
10. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
11. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
13. The CD47-SIRPα signalling system: its physiological roles and therapeutic application.
Murata Y; Kotani T; Ohnishi H; Matozaki T
J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice.
Waern JM; Yuan Q; Rüdrich U; Becker PD; Schulze K; Strick-Marchand H; Huntington ND; Zacher BJ; Wursthorn K; DiSanto JP; Guzman CA; Manns MP; Ott M; Bock M
Hepatology; 2012 Oct; 56(4):1479-88. PubMed ID: 22535707
[TBL] [Abstract][Full Text] [Related]
15. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47.
Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K
J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842
[TBL] [Abstract][Full Text] [Related]
16. The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Beizavi Z; Gheibihayat SM; Moghadasian H; Zare H; Yeganeh BS; Askari H; Vakili S; Tajbakhsh A; Savardashtaki A
Mol Biol Rep; 2021 Jul; 48(7):5707-5722. PubMed ID: 34275112
[TBL] [Abstract][Full Text] [Related]
17. CD47 functions as a molecular switch for erythrocyte phagocytosis.
Burger P; Hilarius-Stokman P; de Korte D; van den Berg TK; van Bruggen R
Blood; 2012 Jun; 119(23):5512-21. PubMed ID: 22427202
[TBL] [Abstract][Full Text] [Related]
18. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo.
Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC
Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932
[TBL] [Abstract][Full Text] [Related]
19. The CD47 pathway is deregulated in human immune thrombocytopenia.
Catani L; Sollazzo D; Ricci F; Polverelli N; Palandri F; Baccarani M; Vianelli N; Lemoli RM
Exp Hematol; 2011 Apr; 39(4):486-94. PubMed ID: 21211546
[TBL] [Abstract][Full Text] [Related]
20. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]